Publications/ Eng

Clinical Intervention Model (CIM)

5-azacitidine use in Quebec’s university teaching hospitalsCIM, descriptive analysis, 2015

Abbreviations and symbols used on prescriptions in Quebec’s university teaching hospitalsCIM, descriptive analysis,  2016

Antifungal use in Quebec’s university teaching hospitalsCIM, descriptive analysis, 2017

Biosimilars: State of Knowledge and Recommendations for Quebec’s University Teaching  HospitalsCIM, Comprehensive evaluation, 2017

Bortezomib use in Quebec’s university teaching hospitalsCIM, descriptive analysis, 2015

Dexmedetomidine use in intensive care in Quebec’s university teaching hospitals based on the utilization criteria established by the TDMP in 2010CIM, descriptive analysis, 2010

Ipilimumab in the treatment of metastatic or unresectable advanced melanoma in Quebec’s university teaching hospitals – CIM, descriptive analysis, 2016

Prescribing and use of rituximab as maintenance therapy for follicular lymphoma in Quebec’s university teaching hospitals – CIM, summary evaluation 2013

Surgical antibiotic prophylaxis in Quebec’s university teaching hospitalsCIM, descriptive analysis, 2014

Drug evaluations

Descriptive analysis/drug utilization reviews

Treatment review

 Posters

Descriptive Analysis of antifungals use in five university teaching hospitals in QuebecASM Microbe juin 2017

5-Azacitidine descriptive analysis (Eng) – CAPhO avril 2016

Bortezomib descriptive analysis (Eng)CAPhO avril 2016

Descriptive analysis and utilization review of meropenem in five university teaching hospitals ICAAC septembre 2011 

Publications/abstracts

Presentations

Advertisements
Advertisements
%d blogueurs aiment ce contenu :